ANIP
ANI Pharmaceuticals Inc
NASDAQ: ANIP · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$77.97
-0.68% today
Updated 2026-04-29
Market cap
$1.77B
P/E ratio
23.48
P/S ratio
2.01x
EPS (TTM)
$3.32
Dividend yield
—
52W range
$57 – $100
Volume
0.4M
ANI Pharmaceuticals Inc (ANIP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
8.87%
Operating margin
12.00%
ROE
16.20%
ROA
3.82%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $14.44M | $2.79M | 100.00% | 23.82% | 19.33% |
| 2007 | $493054.00 | $-7.58M | 100.00% | -1,760.34% | -1,538.26% |
| 2008 | $3.78M | $-17.43M | 100.00% | -476.45% | -460.88% |
| 2009 | $1.26M | $-47.53M | 100.00% | -3,054.36% | -3,777.88% |
| 2010 | $2.47M | $-46.20M | 89.14% | -1,762.50% | -1,867.09% |
| 2011 | $435160.00 | $-51.61M | 88.51% | -11,703.01% | -11,859.66% |
| 2012 | $2.30M | $-27.72M | -298.44% | -1,007.14% | -1,204.73% |
| 2013 | $30.08M | $301000.00 | 66.84% | 2.99% | 1.00% |
| 2014 | $55.97M | $28.75M | 79.50% | 35.74% | 51.36% |
| 2015 | $76.32M | $15.38M | 83.37% | 42.84% | 20.14% |
| 2016 | $128.62M | $3.93M | 62.07% | 15.61% | 3.06% |
| 2017 | $176.84M | $-1.08M | 55.31% | 16.02% | -0.61% |
| 2018 | $201.58M | $15.49M | 63.77% | 17.54% | 7.69% |
| 2019 | $206.55M | $6.09M | 69.42% | 7.92% | 2.95% |
| 2020 | $208.47M | $-22.55M | 58.19% | -7.68% | -10.82% |
| 2021 | $216.14M | $-42.60M | 53.45% | -18.41% | -19.71% |
| 2022 | $316.38M | $-47.90M | 56.13% | -11.15% | -15.14% |
| 2023 | $486.82M | $18.78M | 62.71% | 9.65% | 3.86% |
| 2024 | $614.38M | $-18.52M | 59.27% | 0.10% | -3.01% |
| 2025 | $883.37M | $78.34M | 51.01% | 9.20% | 8.87% |